title: Anti-IgE- and anti-IgA-induced eosinophil migration in atopics and healthy volunteers.
authors.affiliation: UCB Pharmaceutical Sector, Belgium.
authors.forename: J P
authors.initials: JP
authors.lastname: Rihoux
authors.forename: M
authors.initials: M
authors.lastname: Melac
authors.forename: E
authors.initials: E
authors.lastname: Henocq
mesh_terms: D000293:Adolescent; D000328:Adult; D002465:Cell Movement; D004311:Double-Blind Method; D004804:Eosinophils / Q000276:immunology*; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D006969:Hypersensitivity, Immediate / Q000276:immunology*; D007073:Immunoglobulin E / Q000276:immunology*; D007074:Immunoglobulin G / Q000276:immunology*; D008297:Male; D011897:Random Allocation
chemical_list: D006634:Histamine H1 Antagonists; D007074:Immunoglobulin G; D007073:Immunoglobulin E